Therapeutics and COVID‐19—A living WHO guideline: Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine | Zendy

Møller Morten H. | Zendy; Chew Michelle S. | Zendy; Olkkola Klaus T. | Zendy; Rehn Marius | Zendy; YliHankala Arvi | Zendy; Sigurðsson Martin I. | Zendy

Premium

Therapeutics and COVID‐19—A living WHO guideline: Endorsement by the Scandinavian Society of Anaesthesiology and Intensive Care Medicine

Author(s) -

Møller Morten H.,

Chew Michelle S.,

Olkkola Klaus T.,

Rehn Marius,

YliHankala Arvi,

Sigurðsson Martin I.

Publication year - 2022

Publication title -

acta anaesthesiologica scandinavica

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.738

H-Index - 107

eISSN - 1399-6576

pISSN - 0001-5172

DOI - 10.1111/aas.14046

Subject(s) - medicine , guideline , covid-19 , intensive care , trustworthiness , medline , family medicine , intensive care medicine , virology , outbreak , pathology , infectious disease (medical specialty) , computer security , disease , computer science , political science , law

The Clinical Practice Committee of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine endorses the Living WHO guideline on therapeutics and COVID ‐ 19 . This trustworthy continuously updated guideline serves as a highly useful decision aid for Nordic anaesthesiologists caring for patients with COVID‐19.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research